88 related articles for article (PubMed ID: 29338983)
1. Dipyridamole plus Triflusal versus Triflusal Alone in Infarct Reduction after Middle Cerebral Artery Occlusion.
Amtul Z; Haque W; Cechetto DF
J Stroke Cerebrovasc Dis; 2018 May; 27(5):1283-1287. PubMed ID: 29338983
[TBL] [Abstract][Full Text] [Related]
2. Effects of triflusal and aspirin in a rat model of cerebral ischemia.
Whitehead SN; Bayona NA; Cheng G; Allen GV; Hachinski VC; Cechetto DF
Stroke; 2007 Feb; 38(2):381-7. PubMed ID: 17194886
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of triflusal and its main metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid (HTB), in the postischemic brain.
Kim SW; Choi KJ; Park JY; Yoon SH; Lee JK
Neurosci Lett; 2017 Mar; 643():59-64. PubMed ID: 28189746
[TBL] [Abstract][Full Text] [Related]
5. Protective effect of treatment with low-dose gliclazide in a model of middle cerebral artery occlusion and reperfusion in rats.
Tan F; Li H; Ma M; Yu Y
Brain Res; 2014 Apr; 1560():83-90. PubMed ID: 24602692
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute post-treatment with dipyridamole in a rat model of focal cerebral ischemia.
García-Bonilla L; Sosti V; Campos M; Penalba A; Boada C; Sumalla M; Hernández-Guillamon M; Rosell A; Montaner J
Brain Res; 2011 Feb; 1373():211-20. PubMed ID: 21146508
[TBL] [Abstract][Full Text] [Related]
7. Emulsified Isoflurane Protects Against Transient Focal Cerebral Ischemia Injury in Rats via the PI3K/Akt Signaling Pathway.
Zhang H; Xiong X; Liu J; Gu L; Li F; Wan Y; Xu S
Anesth Analg; 2016 May; 122(5):1377-84. PubMed ID: 26859875
[TBL] [Abstract][Full Text] [Related]
8. The Synergistic Neuroprotective Effects of Combined Rosuvastatin and Resveratrol Pretreatment against Cerebral Ischemia/Reperfusion Injury.
Liu Y; Yang H; Jia G; Li L; Chen H; Bi J; Wang C
J Stroke Cerebrovasc Dis; 2018 Jun; 27(6):1697-1704. PubMed ID: 29525080
[TBL] [Abstract][Full Text] [Related]
9. Effects of dexmedetomidine after transient and permanent occlusion of the middle cerebral artery in the rat.
Kuhmonen J; Haapalinna A; Sivenius J
J Neural Transm (Vienna); 2001; 108(3):261-71. PubMed ID: 11341477
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats.
Chauhan A; Sharma U; Jagannathan NR; Reeta KH; Gupta YK
Behav Brain Res; 2011 Dec; 225(2):603-9. PubMed ID: 21903138
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
12. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
[TBL] [Abstract][Full Text] [Related]
13. Curcumin upregulates transcription factor Nrf2, HO-1 expression and protects rat brains against focal ischemia.
Yang C; Zhang X; Fan H; Liu Y
Brain Res; 2009 Jul; 1282():133-41. PubMed ID: 19445907
[TBL] [Abstract][Full Text] [Related]
14. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
[TBL] [Abstract][Full Text] [Related]
15. Combination of Zizyphus jujuba and silymarin showed better neuroprotective effect as compared to single agent in MCAo-induced focal cerebral ischemia in rats.
Gupta S; Gupta YK
J Ethnopharmacol; 2017 Feb; 197():118-127. PubMed ID: 27452658
[TBL] [Abstract][Full Text] [Related]
16. Montelukast, a cysteinyl leukotriene receptor-1 antagonist, dose- and time-dependently protects against focal cerebral ischemia in mice.
Yu GL; Wei EQ; Zhang SH; Xu HM; Chu LS; Zhang WP; Zhang Q; Chen Z; Mei RH; Zhao MH
Pharmacology; 2005 Jan; 73(1):31-40. PubMed ID: 15452361
[TBL] [Abstract][Full Text] [Related]
17. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of nobiletin on cerebral ischemia-reperfusion injury in transient middle cerebral artery-occluded rats.
Yasuda N; Ishii T; Oyama D; Fukuta T; Agato Y; Sato A; Shimizu K; Asai T; Asakawa T; Kan T; Yamada S; Ohizumi Y; Oku N
Brain Res; 2014 Apr; 1559():46-54. PubMed ID: 24534366
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective activity of creatylglycine ethyl ester fumarate.
Veselkina OS; Morozov VA; Korzhevskii DE; Tihonov DB; Barygin OI; Isaeva AV; Portsel MN; Vlasov TD
J Stroke Cerebrovasc Dis; 2015 Mar; 24(3):591-600. PubMed ID: 25561316
[TBL] [Abstract][Full Text] [Related]
20. Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.
Tamás A; Reglõdi D; Szántó Z; Borsiczky B; Németh J; Lengvári I
Neuro Endocrinol Lett; 2002 Jun; 23(3):249-54. PubMed ID: 12080287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
